{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:26:04Z","timestamp":1761128764331},"reference-count":21,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2009,7,3]],"date-time":"2009-07-03T00:00:00Z","timestamp":1246579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tropical Med Int Health"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Objectives\u2002<\/jats:bold> To determine mortality among assumed TB negative (aTBneg) individuals in Guinea\u2010Bissau and to investigate whether plasma levels of soluble urokinase receptor (suPAR) can be used to determine post\u2010consultation mortality risk.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> This prospective West\u2010African cohort study included 1007 aTBneg individuals who were enrolled from 2004 to 2006; 4983 age\u2010matched controls were followed for comparison. Plasma suPAR levels were measured using the suPARnostic<jats:sup>\u00ae<\/jats:sup> ELISA. Survival was analysed using Cox regression, ROC curves and Kaplan\u2013Meier analysis.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> After 3\u2003months of follow\u2010up, mortality was 21 per 100 person\u2010year\u2010observation (PYO) among aTBneg individuals and three per 100 PYO among the control population [mortality rate ratio (MRR)\u2003=\u20036.92 (95% CI 4.48\u201310.7)]. SuPAR values ranged between 0.9 and 45\u2003ng\/ml in aTBneg individuals. A log\u2010linear relationship was found between suPAR levels &lt;15\u2003ng\/ml and mortality. In the log\u2010linear range, a 1\u2003ng\/ml increase was associated with a 46% increase in the mortality rate: MRR\u2003=\u20031.46 (95% CI 1.34\u20131.59). The area under the ROC curves was 0.88 for HIV\u2010positive individuals and 0.79 for HIV\u2010negative individuals.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Our study showed a high mortality rate among aTBneg individuals and demonstrated that suPAR measurements can provide prognostic information on mortality among individuals without disease diagnosis. Measuring suPAR is a technically simple method for determining mortality risk in individuals that are assumed to be TB\u2010negative.<\/jats:p>","DOI":"10.1111\/j.1365-3156.2009.02328.x","type":"journal-article","created":{"date-parts":[[2009,7,3]],"date-time":"2009-07-03T08:43:07Z","timestamp":1246610587000},"page":"986-994","source":"Crossref","is-referenced-by-count":19,"title":["High mortality risk among individuals assumed to be TB\u2010negative can be predicted using a simple test"],"prefix":"10.1111","volume":"14","author":[{"given":"Paulo","family":"Rabna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Wejse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor Francisco","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya Bonde","family":"Haaland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Aaby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper","family":"Eugen\u2010Olsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,8,24]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2001.00818.x"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.22.2767"},{"key":"e_1_2_6_4_1","first-page":"686","article-title":"The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea\u2010Bissau","volume":"6","author":"Eugen\u2010Olsen J","year":"2002","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/16.24.7279"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyh026"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(98)91766-2"},{"key":"e_1_2_6_8_1","first-page":"50","volume-title":"TB\/HIV: A Clinical Manual","author":"Harries AD","year":"2004"},{"key":"e_1_2_6_9_1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1042\/bj3580673","article-title":"Urokinase\u2010catalyzed cleavage of the urokinase receptor requires an intact glycolipid anchor","volume":"358","author":"Hoyer\u2010Hansen G","year":"2001","journal-title":"Biochemistry Journal"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-007-0447-5"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2008.02.003"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200612058"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000157950.02076.a6"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1086\/428854"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612033454630"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1996.tb00502.x"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.022652999"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-7-134"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2007.02.001"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.13.4091"},{"key":"e_1_2_6_21_1","volume-title":"Global Tuberculosis Control: Surveillance, Planning, Financing","author":"WHO","year":"2007"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2004.00850.x"}],"container-title":["Tropical Medicine &amp; International Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-3156.2009.02328.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-3156.2009.02328.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T18:29:04Z","timestamp":1696962544000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-3156.2009.02328.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,24]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1111\/j.1365-3156.2009.02328.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-3156.2009.02328.x","archive":["Portico"],"relation":{},"ISSN":["1360-2276","1365-3156"],"issn-type":[{"value":"1360-2276","type":"print"},{"value":"1365-3156","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,24]]}}}